NCT07120347 · RECRUITING

Remote Sensing for ADRD-Specific Activities Identification in Older Adults

This study puts smart-home sensors and AI into the homes of older adults, some with mild cognitive impairment or early dementia and some without, to see whether the technology can detect changes in everyday activities that signal cognitive decline. It is a Phase NA trial, meaning it is observational and feasibility-focused rather than testing a treatment. Details on exact enrollment numbers are limited so far.

You may qualify if

  • Community-dwelling, English-speaking adults aged ≥ 50 years
  • Clinical diagnosis of mild cognitive impairment or mild dementia (ADRD)
  • Diagnosis established by a neuropsychologist, neurologist, or geriatrician within the University of Missouri Healthcare System
  • Diagnosis confirmed using the latest consensus criteria and verified through record review
  • No restriction on the etiology of the cognitive disorder (e.g., Alzheimer's disease, vascular dementia, mixed dementia)

You're excluded if

  • Clinical Dementia Rating (CDR) global score > 1 (moderate or severe dementia)
  • Cognitive or functional impairments that would preclude meaningful participation in daily activities

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-13

View full record on ClinicalTrials.gov

All APOE4 clinical trials